6 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01364 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | 786-0 | Renal cancer | IC50 : 5 μM |
| dbacp02025 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | 786-0 | Renal cancer | IC50 : 12.2 µg/ml |
| dbacp02083 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | 786-0 | Not specified | IC50 : 12.2 µg/ml |
| dbacp06156 | StigA16 | FFKLIPKLVKGLISAF | Amino acid substitution, amino acid truncation, animal-derived, natural derivative | Disruption of cell membrane | MTT assay | 786-0 | Human cervix adenocarcinoma | IC 50 : 13.01 μM |
| dbacp06161 | StigA6 | FFSLIPKLVKGLISAFK | Amino acid substitution, animal-derived, natural derivative | Disruption of cell membrane | MTT assay | 786-0 | Human cervix adenocarcinoma | IC 50 : 14.01 μM |
| dbacp06766 | M1-21 | rrrqrrkkrg-QTQPRLGPPQTPAGGCSILIF | Synthetic | FOXM1 inhibitor | Cell Viability assay | 786-0 | Renal Cancer | IC50 = 13.5 µM |